During the past decade, Mid North Coast Cancer Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid North Coast Cancer Institute" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "BeiGene" with 2 trials sponsored and "AVEO Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid North Coast Cancer Institute" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Biodesix, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Mid North Coast Cancer Institute" are "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Solid Tumors" (2 trials), "Breast Adenocarcinoma" (1 trials) and "Cancer of the Prostate" (1 trials). Many other conditions were trialed in "Mid North Coast Cancer Institute" in a lesser frequency.

Most popular intervention types in "Mid North Coast Cancer Institute" are "Drug" (15 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (4 trials), "Placebo" (3 trials), "Atezolizumab" (2 trials), "placebo" (2 trials) and "5-Fluouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid North Coast Cancer Institute" are 10 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mid North Coast Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mid North Coast Cancer Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mid North Coast Cancer Institute, 5 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".